ClinicalTrials.gg
RecruitingNCT05507073Updated Sep 8, 2023

A Comparison of Impingement Free Range of Motion With CT Scan After Manual and Robotic Total Hip Replacement

An interventional study of Manual Total Hip Replacement and Robot-Assisted Total Hip Replacement in Hip Osteoarthritis, Post-traumatic Osteoarthritis and Inflammatory Arthritis, sponsored by The Royal Orthopaedic Hospital NHS Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-08.

Sponsored by The Royal Orthopaedic Hospital NHS Trust · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 2 months after the study started (first participant enrolled Apr 2021, registered Jun 2022).
  • Started Apr 2021; still recruiting 5 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 32 studies in Osteoarthritis, Hip with a site in United Kingdom — 5 open to participants now, 11 under way, none of them phase 3. Osteoarthritis, Hip · United Kingdom.

Planned enrollment
16th of 23
50 · median 125
Started
2021
with 2 others
No phase
14 of 32
3 open now
Primary completion
2024-12
later than 3 of 10 live
Registered
26th of 32
by date

Among the 32 studies in Osteoarthritis, Hip with a site in United Kingdom, this one is the 16th largest by planned enrollment of the 23 interventional ones that give a count, is one of 3 that started in 2021, is one of 14 with no phase, reaches primary completion later than 3 of the 10 other live ones, and was the 26th registered.

Osteoarthritis, Hip

641 studies on the registry are indexed under Osteoarthritis, Hip; 120 are open to participants now.

Browse Osteoarthritis, Hip studies →

Open to participants now

5 of the 32 studies in Osteoarthritis, Hip with a site in United Kingdom are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 87 Osteoarthritis, Hip studies recruiting now, 54 (62%) set no upper age limit and 7 (8%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Osteoarthritis, Hip with a site in United Kingdom, or all of them as a file.
02

Study summary

Single-blinded randomised controlled trial comparing impingement with CT scan for manual and robotic total hip replacement. A pilot study of 50 participants.

Read the detailed description

This will be a two-arm, single blind (assessor blind), randomised controlled group study. It will take place in the NHS hospital setting. Stratification will be performed for age and sex by means of a minimisation technique during randomisation for each subject entering the trial.

Arm 1: Manual total hip replacement with conventional templating Arm 2: Robotic total hip replacement In the study 25 participants will receive manual THR with conventional templating; the other 25 will receive Robotic THR.

Following recruitment in outpatient clinics, participants will undergo baseline assessments, including imaging and clinical assessment. All participants will then undergo THR surgery, which will likely entail an inpatient hospital stay of 1-2 days. Post-operative rehabilitation will be in line with the normal standard care for all participants. Post-operatively participants will make two visits to clinic at 6 weeks and 12 months (standard of care).

03

Conditions studied

  • Hip Osteoarthritis
  • Post-traumatic Osteoarthritis
  • Inflammatory Arthritis
  • Congenital Hip Problems
  • Avascular Necrosis of Hip

Keywords

  • hip replacement
  • THR
  • Robotic
  • Arthroplasty
  • Hip Surgery
  • Range of Motion
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participant is willing and able to give for participation in the trial
  • Male or Female, aged 18 to 85 years at recruitment into trial
  • Diagnosed with hip OA, post-traumatic OA, inflammatory arthropathy, , or congenital or developmental hip disease, avascular necrosis of the hip
  • Listed for total hip replacement
  • Suitable for Accolade 2 stem and Trident cup prostheses
  • Female participants of child bearing potential must be willing to ensure that they use effective during the trial
  • In the Investigator's opinion, is able and willing to comply with all trial requirements
  • Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the trial.

Exclusion criteria

Exclusion Criteria:

  • Inability to provide
  • Previous surgery to the ipsilateral hip and implantation of metalwork.
  • Significant co-morbidities that would make follow up difficult or uncomfortable
  • Scheduled elective surgery or other procedures requiring general anaesthesia during the trial.
  • Pregnancy or intention to become pregnant within the trial period.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Manual Total Hip Replacement

    Manual Total Hip Replacement

    Procedure: Manual Total Hip Replacement

  • Experimental
    Robot-Assisted Total Hip Replacement

    Robot-Assisted Total Hip Replacement

    Procedure: Robot-Assisted Total Hip Replacement

Interventions

  • ProcedureManual Total Hip Replacement

    Implantation of a hip Device to alleviate pain and recover range of movement

    Also known as: Hip Arthroplasty, Hip Replacement, Total Hip Replacement

  • ProcedureRobot-Assisted Total Hip Replacement

    Robot assisted Implantation of a hip Device to alleviate pain and recover range of movement

    Also known as: Hip replacement, Robotic Hip replacement, Robot Assisted Hip Arthroplasty

06

What researchers measure

Primary outcomes

  1. Impingement analysis by a CT guided software in all participants to enable a comparison of post-operative impingement between robotic THR and manual THR

    To compare efficacy of Robotic THR in reducing post-operative impingement with Standard Manual THR

    Time frame: 6 weeks post-intervention

Secondary outcomes

  1. Using the Forgotten Joint Score (FJS-12) to determine improvement in Patient reported outcome measures

    To determine whether the Robotic THR improves patient reported outcome measures

    Time frame: 12 months

  2. Using the Oxford Hip score to determine improvement in Patient reported outcome measures

    To determine whether the Robotic THR improves patient reported outcome measures

    Time frame: 12 months

  3. Using the EuroQol 5-D (EQ5-D) to determine improvement in Patient reported outcome measures

    To determine whether the Robotic THR improves patient reported outcome measures

    Time frame: 12 months

  4. Measure leg length following surgery to determine whether robotic THR or manual THR is more effective at reducing leg length discrepancy.

    To determine whether Robotic Surgery reduces leg length Discrepancy compared to manual THR

    Time frame: 12 months

  5. Measure the duration of surgery and compare the duration of robotic THR to manual THR

    To determine whether the Robotic THR increases operation duration compared to Manual surgery

    Time frame: During Surgery

  6. Measure and compare the length of stay between Robotic and Manual THR surgeries

    To determine if length of hospital stay is reduced after robotic THR .

    Time frame: During length of stay in hospital average 3 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2021 (actual). Primary completion is estimated for Dec 2024, 44 months after the start.

Of 200 non-industry interventional studies with no phase under Osteoarthritis, Hip, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 44 months is above that.

Counting every sponsor, half of 226 studies reached it within 29 months; a quarter within 14 and three quarters within 51.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 27, 2022
First posted
Aug 18, 2022
StartActual
Apr 6, 2021
Primary completionEst.
Dec 30, 2024
CompletionEst.
Dec 30, 2024
Last update
Sep 8, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05507073
Lead sponsor
The Royal Orthopaedic Hospital NHS Trust
Collaborators
Stryker Nordic
Responsible party
Sponsor
First posted
Aug 18, 2022
Start date
Apr 6, 2021
Primary completion
Dec 30, 2024 (estimated)
Completion
Dec 30, 2024 (estimated)
Last update
Sep 8, 2023

Study contacts

Edward T Davis, MD
Contact
edward.davis@nhs.net
01216854000 ext. 55306
Sam C Papadopoullos, BSc
Contact
sam.papadopoullos@nhs.net
01216854000 ext. 55306

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion